Powered by

In Vitro Diagnostics: Five News Stories of Note - March 2017

Kalorama Information has noted five news developments in IVD that should be important to those following the industry.  This month the FDA granted a CLIA waiver to Alere's point-of-care (POC) RSV test, and the POC testing market has reached $18.4 billion in sales and continues to grow. An Alere subsidiary is facing a legal battle and the acquisition by Abbott is still in limbo. Meanwhile, Beckman Coulter launched a new chemistry analyzer and researchers evaluated fetal fibronectin screening fo

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox